Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENGAGE AF-TIMI 48
jRCT2080220747Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of edoxaban in Atrial fibrillation (AFib) (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080220747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220747.